Scientific Advisory Board
Board of Trustees
Partnership with MJFF
Research & Clinical Trials
In the News
Glucocerebrosidase is shaking up the synucleinopathies, Siebert et. al.
Multi-center analysis of glucocerebrosidase mutations in Parkinson disease, Sidransky et. al.
Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies, Sardi et. al.
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease, Neumann et. al.
Glucocerebrosidase activity in Parkinson’s disease with and without GBA mutations, Alcalay et. al.